Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Finch Therapeutics Group stock

Learn how to easily invest in Finch Therapeutics Group stock.

Finch Therapeutics Group Inc is a biotechnology business based in the US. Finch Therapeutics Group shares (FNCH) are listed on the NASDAQ and all prices are listed in US Dollars. Finch Therapeutics Group employs 191 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Finch Therapeutics Group

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FNCH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Finch Therapeutics Group stock price (NASDAQ: FNCH)

Use our graph to track the performance of FNCH stocks over time.

Finch Therapeutics Group shares at a glance

Information last updated 2022-01-10.
Latest market close$9.10
52-week range$8.77 - $22.50
50-day moving average $12.62
200-day moving average $13.74
Wall St. target price$30.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.78

Buy Finch Therapeutics Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Finch Therapeutics Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Finch Therapeutics Group price performance over time

Historical closes compared with the close of $9.1 from 2022-01-14

1 week (2022-01-07) -0.76%
1 month (2021-12-16) -6.57%
3 months (2021-10-15) -23.85%
6 months (2021-07-16) -43.48%
1 year (2021-01-12) N/A
2 years (2020-01-12) N/A
3 years (2019-01-12) N/A
5 years (2017-01-12) N/A

Finch Therapeutics Group financials

Revenue TTM $19.5 million
Gross profit TTM $-25,425,000
Return on assets TTM -18.33%
Return on equity TTM -35.61%
Profit margin -267.22%
Book value $4.63
Market capitalisation $435.4 million

TTM: trailing 12 months

Finch Therapeutics Group share dividends

We're not expecting Finch Therapeutics Group to pay a dividend over the next 12 months.

Finch Therapeutics Group overview

Finch Therapeutics Group, Inc. , a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that has completed Phase II clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and FIN-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and crohn's disease. The company has collaboration and license agreements with Millennium Pharmaceuticals, Inc. ; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc.

Frequently asked questions

What percentage of Finch Therapeutics Group is owned by insiders or institutions?
Currently 49.191% of Finch Therapeutics Group shares are held by insiders and 17.329% by institutions.
How many people work for Finch Therapeutics Group?
Latest data suggests 191 work at Finch Therapeutics Group.
When does the fiscal year end for Finch Therapeutics Group?
Finch Therapeutics Group's fiscal year ends in December.
Where is Finch Therapeutics Group based?
Finch Therapeutics Group's address is: 200 Inner Belt Road, Somerville, MA, United States, 02143
What is Finch Therapeutics Group's ISIN number?
Finch Therapeutics Group's international securities identification number is: US31773D1019

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site